Pfizer COVID-19 vaccine 97% effective against symptomatic disease

vaccine
Credit: Pixabay/CC0 Public Domain

The Pfizer COVID-19 vaccine is 97% effective in preventing symptomatic disease in actual use, which is better than previously thought.

The analysis of data gathered from Jan. 17 to March 6 from Israel's vaccination campaign also showed that the is 94 percent effective against asymptomatic disease, CBS News reported.

"We are extremely encouraged that the real-world effectiveness data coming from Israel are confirming the high efficacy demonstrated in our phase 3 clinical trial and showing the significant impact of the vaccine in preventing severe disease and deaths due to COVID-19," said Luis Jodar, Ph.D., senior vice president and chief medical officer of Pfizer Vaccines.

A previous real-world study revealed that the vaccine was 94 percent effective against symptomatic disease and 92 percent effective against asymptomatic disease, CBS News reported.


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: CBS News Article

Copyright © 2020 HealthDay. All rights reserved.

Citation: Pfizer COVID-19 vaccine 97% effective against symptomatic disease (2021, March 15) retrieved 22 June 2021 from https://medicalxpress.com/news/2021-03-pfizer-covid-vaccine-effective-symptomatic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments